Evidence map›Paper›PMID 42564139›Full record

ArticleFrontiers in oncology2026

Optimal peritumoral regions and fusion strategies for prediction of the double-expressor subtype in diffuse large B-cell lymphoma: a multi-region radiomics study.

Qiwen Zhong, Guoxiu Lu, Jingjing Liang, Qi Peng, Ronghui Tian, Guoxu Zhang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qiwen Zhong *Department of Nuclear Medicine, General Hospital of Northern Theatre Command, Shenyang, China.
Guoxiu Lu *Department of Nuclear Medicine, General Hospital of Northern Theatre Command, Shenyang, China.
Jingjing LiangDepartment of Nuclear Medicine, General Hospital of Northern Theatre Command, Shenyang, China.
Qi PengDepartment of Nuclear Medicine, General Hospital of Northern Theatre Command, Shenyang, China.
Ronghui TianSchool of Software, Shenyang University of Technology, Shenyang, Liaoning, China.
Guoxu ZhangDepartment of Nuclear Medicine, General Hospital of Northern Theatre Command, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To develop a PET/CT-based radiomics model for noninvasive prediction of the double-expressor lymphoma (DEL) subtype in diffuse large B-cell lymphoma (DLBCL). Materials and methods: From January 2019 to July 2025 consecutively enrolled, 143 patients with DLBCL (55 DEL, 88 non-DEL) were randomly divided into a training set and an internal validation set in a 7:3 ratio. Radiomic features were extracted from peritumoral regions with different expansion distances (3, 5, and 10 mm) to identify the optimal peritumoral region. These features were then integrated using various fusion strategies (multi-region fusion, image fusion, and feature fusion) for combined intratumoral and peritumoral analysis. A transfer learning model built on a pretrained ResNet-50 was combined with a clinical model incorporating baseline PET features to develop three integrated models (Clinic+Rad+DL, Stacking, Ensemble). Model performance was evaluated to select the best-performing approach, and SHAP analysis was applied to enhance interpretability. Results: The Rad_MLP model achieved the best performance by integrating intratumoral and 10-mm peritumoral features, with an accuracy of 85.3%, a sensitivity of 89.5%, and a specificity of 79.2%. The positive predictive value (PPV) and negative predictive value (NPV) were 0.773 and 0.905, respectively, with an F1 score of 0.829. Conclusion: Rad_MLP, by integrating the most predictive intratumoral and peritumoral features, substantially improves the accuracy of noninvasive prediction of the DEL subtype in DLBCL.

Indexed as

18F-FDG PET/CTdeep learning radiomicsdiffuse large B-cell lymphomadouble-expressor lymphoma (DEL)multi-regional analysis

Identifiers

PMID42564139
PMCPMC13442022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.